EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CD4 + T‐Cell‐Intrinsic IL‐6 Is Critical for Th17 Differentiation and Dampened Responsiveness to CD8 + T Cell‐Mediated Suppression

Chakrapani Vemulawada, Kshitija Kale, Michael P Crawford, Nitin J Karandikar iD

European Journal of Immunology · 2026

DOI: 10.1002/eji.70150 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Immunology, 2026. Verfasst von Chakrapani Vemulawada und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Iowa Health Care and Iowa City VA Medical Center, Iowa City, Iowa, USA. Hauptthemen laut MEDLINE: Interleukin-6, Th17 Cells, Cell Differentiation, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSRD VA, U.S. Department of Veterans Affairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigates the role of T‐cell‐intrinsic IL‐6 in Th17 differentiation and effector resistance. Using CRISPR‐Cas9‐mediated Il6 knockdown in primary human CD4 + T‐cells, we demonstrate that T‐cell‐produced IL‐6 is crucial for the optimal development of Th17 cells. Lack of T‐cell‐endogenous Il6 resulted in impaired IL‐17A production as well as significantly increased responsiveness to immune suppression. Importantly, these effects could not be reversed by the addition of exogenous IL‐6, likely due to interference with Il6R expression in the absence of endogenous Il6 , with consequent reduction in STAT3 phosphorylation. Blockade of IL‐6 receptor replicated the functional effects of Il6 knockdown and revealed a feedback loop between Il6 and Il6R expression. Of note, IL‐21 was able to bypass the need for IL‐6 in both Th17 differentiation and the development of resistance. Our findings emphasize T‐cell‐endogenous IL‐6 as a critical cytokine in Th17 cell biology and highlight IL‐6 and IL‐21 as potential immunotherapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-6Th17 CellsCell DifferentiationCD8-Positive T-LymphocytesCD4-Positive T-LymphocytesHumansSTAT3 Transcription FactorReceptors, Interleukin-6Interleukin-21InterleukinsCells, CulturedInterleukin-17

Stichwörter der Autor:innen

CRISPR‐gene KOIL‐6/IL6RTh17 cellT‐cell intrinsiceffector suppression

Substanzen

Interleukin-6STAT3 Transcription FactorReceptors, Interleukin-6Interleukin-21InterleukinsIL6 protein, humanInterleukin-17STAT3 protein, human

Autor:innen und Institutionen

  • Department of Pathology, University of Iowa Health Care and Iowa City VA Medical Center, Iowa City, Iowa, USA.

ORCID-Profile: Nitin J Karandikar

Förderung

  • CSRD VA
  • U.S. Department of Veterans Affairs

Zitieren

APA

Vemulawada, C., Kale, K., Crawford, M. P., & Karandikar, N. J. (2026). CD4 + T‐Cell‐Intrinsic IL‐6 Is Critical for Th17 Differentiation and Dampened Responsiveness to CD8 + T Cell‐Mediated Suppression. European Journal of Immunology. https://doi.org/10.1002/eji.70150

Vancouver

Vemulawada C, Kale K, Crawford MP, Karandikar NJ. CD4 + T‐Cell‐Intrinsic IL‐6 Is Critical for Th17 Differentiation and Dampened Responsiveness to CD8 + T Cell‐Mediated Suppression. European Journal of Immunology. 2026. doi:10.1002/eji.70150

BibTeX
@article{Vemulawada2026,
  author = {Vemulawada, Chakrapani and Kale, Kshitija and Crawford, Michael P and Karandikar, Nitin J},
  title = {CD4 + T‐Cell‐Intrinsic IL‐6 Is Critical for Th17 Differentiation and Dampened Responsiveness to CD8 + T Cell‐Mediated Suppression},
  journal = {European Journal of Immunology},
  year = {2026},
  doi = {10.1002/eji.70150}
}
Kostenlos starten →